Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications “i was trying do maths” exploring impact risk communication discrete choice experiments
… Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE); August 29, 2017. Montreal, Canada. … that the use of carbamazepine in pregnancy increases the risk for preterm delivery in comparison to no use of … they seem to indicate that there might be an increased risk for preterm delivery. Results for lamotrigine are not …
… compared the model results to generate insights into the impact of these modeling choices on long-term health and … Tate A, Winblad B, Stellick CB, Bruck C, Green C, de Kok I, Hlavka J, Mar J, Urbich M, Soto-Gordoa M, Pemberton-Ross … P, Aye S, Jonsson L, workshop 2023 Participants I. IPECAD modeling workshop 2023 cross comparison challenge …
… Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2018. Prague, Czech Republic. …
… Clinical and Economic Impact of Blood-Based Biomarkers for Mild Traumatic Brain … conducted research to determine the clinical and economic impact of using such tests in the French healthcare setting …
… your analyses and help you better understand the potential impact of your novel healthcare intervention. You rely on … are a useful tool, but they can only assess the direct impact of an intervention. When developing medicines, … and herd immunity to effectively demonstrate the full impact of your product. Infectious disease models can capture …
RTI-HS Researchers Outline Best Practices for Collecting Patient Experience Data During the COVID-19 Outbreak Share on: April 9, 2020 Updated November 10, 2020 Experts on our Patient-Centered Outcomes Assessment (PCOA) team collaborated to create this …
… 2023 Value Assessment Framework Updates: How Might Changes Impact Pharmaceutical Companies? Share on: July 28, 2023 … assessed. Although this new rating may not have a direct impact on how payers view the clinical effectiveness of new … Manufactures should investigate key scenarios that may impact the new treatment’s assessed value. What does this …
… using methods such as propensity scores, when estimating risk measures of association. In addition, we assist …
… Solutions Now is the time for drug manufacturers to do everything they can to get ready for a potential … Note here that the guidance states, “In considering impact on specific populations and patients with unmet … who is younger, non-disabled, or not terminally ill”—i.e., the use of quality-adjusted life-years (QALYs) in not …
DIA China 2022 Annual Meeting Share on: Thursday, July 21 - Sunday, July 24, 2022 Conference Website * This event has been postponed. Details of reschedule date forthcoming. * RTI Health Solutions researcher Xabier Garcia de Albeniz Martinez, Director of …